Sab Biotherapeutics

Developer of immunotherapeutics to treat infectious and autoimmune diseases

placeSioux Falls, South Dakota, United States calendar_todayFounded 2014 groups56 employees language sab.bio

Registered entities

Innovation

4 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 136 times.

YearFilings
20171
20223
20241

Social engagement

Social engagement: 5.2K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Sioux Falls Development, Merck, SD Equity Partners, Array.

Investor typeCountShare
Accelerator & incubator114%
Other / undisclosed686%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

11 Oct 2025 · Research Associate 2, Product Development · Sioux Falls

Based on job postings tracked across public sources.

Coming soon